About Biocon

Founded Year
5,001 - 10,000 ( View All )
Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthcare through innovative and affordable biopharmaceuticals, we have enabled access to advanced therapies for diseases that are chronic, where medical needs are largely unmet and treatment costs are high. The early anticipation of the increasing dominance of biologics in global development pipelines helped us to be ahead of the curve in crafting a differentiated product portfolio based on fermentation and recombinant technologies, which straddles fermentation-derived small molecules and biologics, both novel as well as biosimilars. The significant brand equity that we have built worldwide for our small molecule APIs across statins, immunosuppresants and other specialty products has made us a leading global supplier of these products. We have also built one of the largest and most diverse biosimilar pipelines, spanning insulins, monoclonal antibodies and other recombinant proteins that address critical chronic diseases such as diabetes, cancer and autoimmune disorders. Ranked among the Top 3 biosimilar players globally for rh-insulin and insulin glargine in volume terms, we are the first Indian company to launch a biosimilar in Japan with Insulin Glargine, which also has been approved for sale in EU and Australia. Our insulin products have made a difference to the lives of millions of people with diabetes across the globe. We now aim to provide our insulin products to ‘one in five’ people with diabetes in need of insulin-based therapy anywhere in the world within the next 10 years. We are also making a huge impact in the area of cancer care. Our biosimilar Trastuzumab, which was the first to be approved anywhere in the world and launched in India in 2014, has helped treat several thousand HER2-positive metastatic breast cancer patients. We are also the first company from India to get its biosimilar approved by the USFDA; Ogivri™, co-developed by Biocon and Mylan, is the first biosimilar Trastuzumab to be approved in the US. In addition to Trastuzumab, several of our biosimilar assets are on track for anticipated regulatory approvals in developed markets. We are also developing a pipeline of patented biologics to address global unmet medical needs. We have successfully launched a couple of novel biologics in India: Nimotuzumab for the treatment of head and neck cancer and Itolizumab to tackle psoriasis. Besides these, we have a basket of novel assets are under various stages of clinical development, including a high potential oral insulin. Through our subsidiary, Syngene, we offer a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) to the global life sciences sector. Ranked by the prestigious Science magazine among the Top 10 Best employers in the biotech industry, Biocon is passionately pursuing a mission to rationalize healthcare spends, enhance access to life-saving therapies and make a significant impact to global healthcare through ‘blockbuster’ drugs with the potential to benefit a billion patients.

Top employees of Biocon

Yogesh Lawania

Head- API Planning & Global Logistics

Phone Email
Prasad Deshpande

Senior Vice President AND Head OF Global Procurement, Supply Chain AND Contract Manufacturing

Phone Email
Raheel Ahmed

Therapy Manager - Breast Cancer

Phone Email
Ashwin Premkumar


Phone Email
Amrita Ganguly

Senior Executive HR

Phone Email

Best Alternatives to Biocon

Biotechnology Innovation Organization
Biotechnology Innovation Organization

United States

View all employees


Hong Kong SAR China

View all employees

BioFire Diagnostics, LLC
BioFire Diagnostics, LLC

United States

View all employees

Start with AroundDeal For Free!

Instant access. Cancel anytime

Frequently Asked Questions Regarding Biocon

Where is Biocon's headquarter located?
Biocon's headquarter located in India.
How many employees does Biocon have?
5,001 - 10,000
What is Biocon website?

Find Your Next Customer with Better Data

Get access to over 120 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.

Top-ranked on G2 Crowd

GDPR compliantCancel anytime

"Great for all new business and account management professionals"

I've been using AroundDeal for a while now and it has become my 'go to tool' when prospecting new business. Accurate, easy to use and effective.

Tim C.

Senior Sales Manager

"AroundDeal is a great tool for getting deals on your business."

We love AroundDeal and we are surprised how it does what it says. Our company use this platform for our getting prospects and it works always.

Ibrahim A.

Founder and CEO

"I use Linkedin to find investors in my business and AroundDeal allowed me to find emails."

I am able to find investors emails that were not available on their linkedin profile which were helpful.

James M

Sales and Marketing Manager/Owner

"Accurate Information"

I have used several Contact Finder programs, and this was the first to provide details that I can rely on in emails and phone numbers.

Mike P.

Business Development Executive


That portal was very helpful for us, Authentic contacts, email , numbers and no any other bugs in this website.

Pradeep K.

Admin Manager

"It was really a best search engine experience."

I Like the interface and search engine. Searching for any contact made easy in this Pandemic. It was perfect, and anyone can use it easily.

Navneet K.

Assistant Vice President

Find Leads in 1 Click

Connect with anyone with AroundDeal today!

Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.

✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts